Ascendis Pharma

Ascendis Pharma is one of Europe's major biotech businesses, headquartered in Copenhagen, Denmark, with the purpose of improving patients' lives through creative drug development. Since its inception in 2007, the company has quickly evolved into a prominent participant in the biotech industry, operating in the United States and Germany.

The team at Ascendis Pharma is driven by a strong vision to make a significant difference in the lives of patients. They intend to accomplish this by developing best-in-class treatments that meet unmet medical needs and improve patient outcomes. The firm focuses on endocrine and metabolic illnesses, and their TransCon technology platform enables the creation of long-acting prodrug medicines with sustained and consistent dosing.

Numerous awards and industry recognition have recognized Ascendis Pharma's commitment to innovation and excellence. The company has a strong pipeline of medication candidates in various phases of research, including treatments for growth hormone insufficiency, achondroplasia, and hypoparathyroidism.

Ascendis Pharma is a premier biotech business that is transforming the healthcare industry. Its commitment to improve patient outcomes, as well as its unique approach to drug development, has positioned it as a prominent leader in the biotech industry, with a bright future ahead.

Founded: 2007

Headquarters: Hellerup, Denmark

Website: https://ascendispharma.com